• Applied Biological Chemistry
• /
• 제47권2호
• /
• pp.258-264
• /
• 2004

한의학에서 당뇨병 (소갈) 처방으로 사용되는 옥천산 처방의 성분 중의 하나인 오미자의 포도당 이용에 대한 효과를 조사하기 위해서 오미자를 70% 에탄올로 추출한 후 메탄올과 물을 섞은 용액으로 단계별로 XAD-4 column 으로 분획하였다. 오미자를 복용한 후 혈당을 낮추기 위해서는 인슐린처럼 작용하는 인슐린성 물질이거나, 인슐린 작용을 향상시키는 인슐린 민감성 물질로 작용하거나, 또는 ${\alpha}-glucoamylase$ 활성을 억제하여 탄수화물의 소화를 방해 작용이 있어야 하므로 본 연구에서는 섬유아세포와 지방세포 3T3-L1에서 각 분획층이 이러한 3가지 기전에 관여하는 지를 조사하였다. 오미자 분획물은 인슐린성 물질로 작용하거나 ${\alpha}-glucoamylase$의 활성을 저하시켜 탄수화물의 소화를 방해하지 않았다. 그러나 오미자 분획층은 인슐린의 작용을 향상시켜 포도당의 흡수를 증가시키는 효과가 매우 컸다. 특히 오미자 분획층 중 Fr. 4(메탄올 60%)와 Fr. 5(메탄올 80%)는 지방세포 3T3-L1에서 포도당의 흡수를 현저하게 증가시켜 인슐린을 50 ng/ml를 처리한 것보다도 효과적으로 포도당 흡수를 증가시켰다. Fr. 4와 Fr. 5에서 포도당 흡수가 증가한 것은 Fr. 4와 5가 인슐린 작용을 향상시켜 세포막에 GLUT4양을 증가시진 결과이었다. 결론적으로 오미자 중 특히 Fr. 4와 Fr. 5에 인슐린 민감성 제제가 함유되어 있을 것으로 추정된다.

• 디지털융복합연구
• /
• 제17권7호
• /
• pp.275-284
• /
• 2019

난초과의 석곡(石斛; Dendrobii herba) 에탄올 추출물(EED)의 항당뇨 활성 및 항당뇨 기전을 조사하였다. 스트렙토 조 토신에 의해 유도된 당뇨병 마우스에서 EED를 하루 4회 경구 투여하여 공복 혈당, 당화혈색소 수치, 인슐린 수치 및 글루탐산 옥살 아세트산 트랜스 아미나 아제 및 글루탐산 피루브산 트랜스 아미나 아제의 간 기능을 감소시키는 실험연구를 통해 그 약리적 기전을 밝혀내고자 했다. EED는 L6 근육 세포에서 세포 내 포도당 섭취뿐만 아니라 RINm5F 베타 세포에서 포도당에 의한 인슐린 분비를 증가시켰다. 따라서 EED는 인슐린 분비를 증가시킬 뿐만 아니라 세포 당 흡수를 증가시킴으로써 항당뇨병 활성을 나타내는데 커다란 가능성을 보여주었으며, 향후 석곡(石斛; Dendrobii herba) 에탄올 추출물에 대한 약리적 기전에 대한 연구가 더욱 활발하게 이루어져 당뇨병 치료에 큰 공헌을 할 수 있게 되기를 기대해본다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권18호
• /
• pp.8053-8058
• /
• 2016

Metformin is known as a hypoglycaemic agent that regulates glucose homeostasis by inhibiting liver glucose production and increasing muscle glucose uptake. Colorectal cancer (CRC) is one of the most common cancers worldwide, with about a million new cases diagnosed each year. The risk factors for CRC include advanced age, smoking, black race, obesity, low fibre diet, insulin resistance, and the metabolic syndrome. We have searched Medline for the metabolic syndrome and its relation to CRC, and metformin as a potential treatment of colorectal cancer. Administration of metformin alone or in combination with chemotherapy has been shown to suppress CRC. The mechanism that explains how insulin resistance is associated with CRC is complex and not fully understood. In this review we have summarised studies which showed an association with the metabolic syndrome as well as studies which tackled metformin as a potential treatment of CRC. In addition, we have also provided a summary of how metformin at the cellular level can induce changes that suppress the activity of cancer cells.

• Toxicological Research
• /
• 제29권1호
• /
• pp.15-19
• /
• 2013

Alloxan administration in rats is used as a model for non-insulin dependent diabetes mellitus (NIDDM). NIDDM is a multifactorial disease, characterized by hyperglycemia and lipoprotein abnormalities. In this study, we evaluated the antihyperglycemic and antihyperlipidemic effects of fermented Rhynchosia nulubilis (FRN) through the regulation of glucose uptake in alloxan-induced rats. Fermented R. nulubilis was administered orally for 28 d at 500 mg/kg of body weight. Body weight and food intake were monitored every day. Biochemical parameters were quantified after 4 week. In the diabetic + FRN group, body weight increased significantly and blood glucose concentrations decreased when compared to those of the diabetic group. After 2 hr of administration, the oral glucose tolerance test (OGTT) indicated a significant reduction in the diabetic + FRN group compared to diabetic group. The diabetic + FRN group experienced a significant reduction in total cholesterol, triglycerides, low density lipoprotein, coronary risk factors, and malondialdehyde concentrations, with significantly increased high density lipoprotein compared to those of diabetic group. These results demonstrate that fermented R. nulubilis possesses potent antihyperglycemic and antihyperlipidemic activity in alloxan-induced diabetic rats.

• 동의생리병리학회지
• /
• 제28권3호
• /
• pp.337-345
• /
• 2014

The present study examined the effects of soybean-derived phosphatidylserine (SB-PS) on the learning and memory function and the neural activity in rats with trimethyltin (TMT)-induced memory deficits. The cognitive improving efficacy of SB-PS on the amnesic rats, which was induced by TMT, was investigated by assessing the Morris water maze test and by performing cholineacetyl transferase (ChAT), acetylcholinesterase (AChE) and cAMP responsive element binding protein (CREB) immunohistochemistry. A positron emission tomography (PET) scanning the rat brain was by performed administer 18F-Fluorodeoxy-glucose (18F-FDG). The rats with TMT injection showed impaired learning and memory of the tasks and treatment with SB-PS produced a significant improvement of the escape latency to find the platform in the Morris water maze at the 2nd day compared to that of the MCT group. In the retention test, the SB-PS group showed increased time spent around the platform compared to that of the MCT group. Consistent with the behavioral data, SB-PS 50 group significantly alleviated the loss of acetyl cholinergic neurons in the hippocampus compared to that of the MCT group. Treatment with SB-PS significantly increased the CREB positive neurons in the hippocampus as compared to that of the MCT group. In addition, SB-PS groups increased the glucose uptake in the hippocampus and SB-PS 50 group increased the glucose uptake in the frontal lobe, as compared to that of the MCT group. These results suggest that SB-PS may be useful for improving the cognitive function via regulation of cholinergic marker enzyme activity and neural activity.

• Biomolecules & Therapeutics
• /
• 제19권3호
• /
• pp.348-356
• /
• 2011

Liriope platyphylla is a medical herb that has long been used in Korea and China to treat cough, sputum, neurodigenerative disorders, obesity and diabetes. The aims of this study were to study the antidiabetic effects of the aqueous extract of L. platyphylla (AEtLP) through pancreatic and extrapancreatic actions. AEtLP were orally administrated to ICR mice once a day for 7 days. Of three different concentrations of AEtLP, only 10% AEtLP were low toxic to liver, based on body weight and serum biochemical analyses. However, 10% AEtLP-treated mice displayed signifi cant reduction of the glucose concentration and increased insulin concentration; no changes were noted using 5% and 15% AEtLP. Also, the increase of glucose transporter (Glut)-1 expression in liver was dependent on the concentration of AEtLP, and was regulated by the phosphorylation of Akt. The lowest expression of Glut-3 was observed in 15% AEtLP treated mice, followed by 10% AEtLP- and 5% AEtLP-treated mice. This pattern of Glut-3 expression was roughly in accord with the phosphorylation of c-Jun N-teminal kinase (JNK) in the mitogen-activated protein kinase (MAPK) pathway. Furthermore, a signifi cant rise of the superoxide dismutase activity (SOD) was detected in AEtLP-treated mice. The fi ndings suggest that AEtLP should be considered as a diabetes therapeutic candidate to induce insulin secretion from pancreatic ${\beta}$-cells and glucose uptake in liver cells.

• 한국미생물·생명공학회지
• /
• 제17권5호
• /
• pp.504-509
• /
• 1989

Streptococcus lactis IFO 12007의 nisin 생산을 위한 발효조건을 검토하였다. Nisin 생성을 위한 포도당의 농도는 60g/ι이며 pH와 온도는 각각 6.5와 3$0^{\circ}C$이었다. 이 조건에서 최대 2,000IU/$m\ell$의 생산량을 보이며 이 때 specific glucose uptake rate: 0.59g/g/h, specific nisin productivity는 34924iu/g/h, growth yield는 0.24, 7시간 후 균체 생산량은 4.81g/ι이었다. 비성장속도는 온도와 pH에 의하여 영향을 많이 받으며 증식활성화 에너지는 1.35kca1/ mole이었다. 유가배양에 의하여 1420IU/$m\ell$의 nisin을 생산하며 연속배양은 0.38h$^{-1}$까지 가능하고 이때 nisin 농도는 740IU/m1, specific nisin productivity는 45000IU/g/h, true growth yield 는 0.144, maintenance energy는 207mg glucose/g-cell/h 이었다.

• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1984년도 학술대회지
• /
• pp.191-197
• /
• 1984

인삼의 저혈당성 분획 (DPG-3-2)이 적출한 랑겔한스섬에서 인슐린 분비를 증가시킨다고 일전에 본 저자들이 발표하였다. 근래에 이와 같은 DPG-3-2 분획으로부터 사포닌, 뉴크레오사이드, 뉴크레오타이드, 아미노산, 당 등을 완전히 제거시켜 더욱 정제한 D-O-ANa 성분을 추출하였다. D-O-ANa 유발성 인슐린 분비효과를 DPG 3-2 분획과 그외 잔여성분과 비교 검토하였다. D-O-ANa는 글루코우즈 농도의 고저에 무관하게 인슐린 분비를 가장 강하게 촉진하였다. 특히 D-O-ANa는 제 2 차증 글루코운즈 유발성 인슐린 분비를 촉진하였다. DPG 3-2 분획은 당뇨병 쥐로부터 떼어낸 랑겔한스섬에서 세포외 체액의 칼슘이온이 증가됨에 따라($0.16{\~}6.25$mM) 글루코우즈 유발성 인슐린 분비를 더욱 현저히 증가시켰다. 칼슘이온 흡수와 인슐린분비의 상호관계가 뚜렷이 밝혀졌다. 이 관계는 single sucrose gap 방법에 의해 주의 적출 간 문맥에서 칼슘주파수가 증가되는 실험을 통해 증명되었다.

• Journal of Ginseng Research
• /
• 제45권5호
• /
• pp.565-574
• /
• 2021

Background: Saengmaeksan (SMS) is a traditional Korean medicine composed of three herbs, Panax ginseng, Schisandra chinensis, and Liriope platyphylla. SMS is used to treat respiratory and cardiovascular disorders. However, whether SMS exerts antihyperuricemic effects is unknown. Methods: Effects of the SMS extract in water (SMS-W) and 30% ethanol (SMS-E) were studied in a rat model of potassium oxonate-induced hyperuricemia. Uric acid concentrations and xanthine oxidase (XO) activities were evaluated in the serum, urine, and hepatic tissue. Using renal histopathology to assess kidney function and uric acid excretion, we investigated serum creatinine and blood urea nitrogen concentrations, as well as protein levels of renal urate transporter 1 (URAT1), glucose transporter 9 (GLUT9), and organic anion transporter 1 (OAT1). The effects of SMS on in vitro XO activity and uric acid uptake were also evaluated. The components of SMS were identified using Ultra Performance Liquid Chromatography (UPLC). Results: SMS-E reduced serum uric acid and creatinine concentrations, and elevated urine uric acid excretion. SMS-E lowered XO activities in both the serum and liver, and downregulated the expression of renal URAT1 and GLUT9 proteins. SMS-E reduced renal inflammation and IL-1b levels in both the serum and kidneys. SMS-E inhibited both in vitro XO activity and urate uptake in URAT1-expressing oocytes. Using UPLC, 25 ginsenosides were identified, all of which were present in higher levels in SMS-E than in SMS-W. Conclusion: SMS-E exhibited antihyperuricemic effects by regulating XO activity and renal urate transporters, providing the first evidence of its applicability in the treatment of hyperuricemia and gout.

• Environmental Analysis Health and Toxicology
• /
• 제13권3_4호
• /
• pp.87-94
• /
• 1998

The use of cisplatin is limited by severe side effects such as renal toxicity. Our platinum-base drug discovery is aimed at developing drugs capable of diminishing toxicity and improving antitumor activity. We synthesized new Pt (II) complex analogue [Pt (cis-DACH)(DPPP)]. 2NO$_3$ (PC) containing cis-1,2-diaminocyclohexane as a carrier ligand and 1,3-bis(diphenylphosphino) propane as a leaving group. Furthermore, nitrate was added to improved the solubility. In this study, its structure was determined and its antitumor activity against SKOV-3 and NIH-OVCAR-3 human ovarian adenocarcinoma, and in vitro cytotoxicity was determined against primary cultured rabbit kidney proximal tubular and renal cortical cells of human kidney using colorimetric MTT assay. PC demonstrated acceptable antitumor activity against SKOV-3 and NIH-OVCAR-3 human ovarian adenocarcinoma and significant activity as compared with that of cisplatin. The toxicity of PC was found quite less than that of cisplatin using MTT and $^3$H-thymidine uptake tests in rabbit proximal tubular cells and human kidney cortical cells. PC was used for human cortical tissue in 7 weeks hitoculture by the glucose-consumption tests. We determined that the new platinum drug has lower nephrotoxicity than cisplatin. Based on these results, this novel platinum (II) complex compound (PC) represent a valuable lead in the development of a new anticancer chemotherapeutic agent capable of improving antitumor activity and low nephrotoxicity.